247 related articles for article (PubMed ID: 22330890)
1. Current status and future challenges of CAR-T cell therapy for osteosarcoma.
Li S; Zhang H; Shang G
Front Immunol; 2023; 14():1290762. PubMed ID: 38187386
[TBL] [Abstract][Full Text] [Related]
2. Targeted immunotherapy of cancer with CAR T cells: achievements and challenges.
Lipowska-Bhalla G; Gilham DE; Hawkins RE; Rothwell DG
Cancer Immunol Immunother; 2012 Jul; 61(7):953-62. PubMed ID: 22527245
[TBL] [Abstract][Full Text] [Related]
3. A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor.
Krug C; Wiesinger M; Abken H; Schuler-Thurner B; Schuler G; Dörrie J; Schaft N
Cancer Immunol Immunother; 2014 Oct; 63(10):999-1008. PubMed ID: 24938475
[TBL] [Abstract][Full Text] [Related]
4. Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity.
Cao JW; Lake J; Impastato R; Chow L; Perez L; Chubb L; Kurihara J; Verneris MR; Dow S
Cancer Immunol Immunother; 2024 Mar; 73(5):77. PubMed ID: 38554158
[TBL] [Abstract][Full Text] [Related]
5. Antigen processing and presentation-related signature-derived BNIP3 is a novel oncogene and immunotherapy determinant in osteosarcoma based on machine learning and in vitro validation.
Chen Y; Cao Y; Wu S; Cao X; Cai T; Hu H
J Gene Med; 2024 Jan; 26(1):e3586. PubMed ID: 37655535
[TBL] [Abstract][Full Text] [Related]
6. Immune reconstitution prevents metastatic recurrence of murine osteosarcoma.
Merchant MS; Melchionda F; Sinha M; Khanna C; Helman L; Mackall CL
Cancer Immunol Immunother; 2007 Jul; 56(7):1037-46. PubMed ID: 17149595
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for Pediatric Gliomas: CAR-T Cells Against B7H3: A Review of the Literature.
Santiago-Vicente Y; de Jesús Castillejos-López M; Carmona-Aparicio L; Coballase-Urrutia E; Velasco-Hidalgo L; Niembro-Zúñiga AM; Zapata-Tarrés M; Torres-Espíndola LM
CNS Neurol Disord Drug Targets; 2024; 23(4):420-430. PubMed ID: 37038673
[TBL] [Abstract][Full Text] [Related]
8. Overall review of curative impact and barriers of CAR-T cells in osteosarcoma.
Li G; Wang H; Meftahpour V
EXCLI J; 2024; 23():364-383. PubMed ID: 38655095
[TBL] [Abstract][Full Text] [Related]
9. T cell responses to tumor: how dominant assumptions on immune activity led to a neglect of pathological functions, and how evolutionary considerations can help identify testable hypotheses for improving immunotherapy.
Kallikourdis M
Cancer Immunol Immunother; 2018 Jun; 67(6):989-998. PubMed ID: 29335855
[TBL] [Abstract][Full Text] [Related]
10. Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy.
Makuku R; Khalili N; Razi S; Keshavarz-Fathi M; Rezaei N
J Immunol Res; 2021; 2021():6661406. PubMed ID: 33681388
[TBL] [Abstract][Full Text] [Related]
11. Generating Recombinant Antibodies to Membrane Proteins through Phage Display.
Huang R; Kiss MM; Batonick M; Weiner MP; Kay BK
Antibodies (Basel); 2016 May; 5(2):. PubMed ID: 31557992
[TBL] [Abstract][Full Text] [Related]
12. Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes.
Shirasu N; Kuroki M
Anticancer Res; 2012 Jun; 32(6):2377-83. PubMed ID: 22641678
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma.
Rainusso N; Brawley VS; Ghazi A; Hicks MJ; Gottschalk S; Rosen JM; Ahmed N
Cancer Gene Ther; 2012 Mar; 19(3):212-7. PubMed ID: 22173710
[TBL] [Abstract][Full Text] [Related]
14. CAR T-cell Therapy: A New Era in Cancer Immunotherapy.
Miliotou AN; Papadopoulou LC
Curr Pharm Biotechnol; 2018; 19(1):5-18. PubMed ID: 29667553
[TBL] [Abstract][Full Text] [Related]
15. Construction and molecular characterization of human chimeric T-cell antigen receptors specific for carcinoembryonic antigen.
Shirasu N; Shibaguci H; Kuroki M; Yamada H; Kuroki M
Anticancer Res; 2010 Jul; 30(7):2731-8. PubMed ID: 20683006
[TBL] [Abstract][Full Text] [Related]
16. Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells.
Fernández L; Metais JY; Escudero A; Vela M; Valentín J; Vallcorba I; Leivas A; Torres J; Valeri A; Patiño-García A; Martínez J; Leung W; Pérez-Martínez A
Clin Cancer Res; 2017 Oct; 23(19):5824-5835. PubMed ID: 28659311
[No Abstract] [Full Text] [Related]
17. Auto T cells expressing chimeric antigen receptor derived from auto antibody might be a new treatment for osteosarcoma.
Weibo P; Zhaoming Y
Med Hypotheses; 2012 May; 78(5):616-8. PubMed ID: 22330890
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]